Csaholczi Bianka, Csuth Anna Renáta, Korponay-Szabó Ilma Rita, Fésüs László, Király Róbert
Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Hungary.
Doctoral School of Molecular Cell and Immune Biology, University of Debrecen, Hungary.
FEBS J. 2025 Feb;292(4):915-928. doi: 10.1111/febs.17373. Epub 2024 Dec 23.
Transglutaminase 2 (TG2) is a uniquely versatile protein with diverse catalytic activities, such as transglutaminase, protein disulfide isomerase, GTPase and protein kinase, and participates in several biological processes. According to information available in the RBP2GO database, TG2 can act as an RNA-binding protein (RBP). RBPs participate in posttranscriptional gene expression regulation, therefore influencing the function of RNA, whereas RNA molecules can also modulate the biological activity of RBPs. The present study aimed to confirm this novel characteristic of TG2 in human umbilical cord vein endothelial cells (HUVEC), which physiologically express TG2. First, UV cross-linked RNA-protein complexes were isolated from immortalised HUVECs using orthogonal organic phase separation. Compared with the RBP2GO database, mass spectrometry identified 392 potential RBPs, including TG2 and 20 previously undescribed, endothelium-related RBPs. Recombinant human TG2 was also pulled down by magnetic bead-immobilised total RNA from HUVEC. Complex formation between TG2 and a 43-mer RNA molecule with a secondary structure as well as a homo-oligomeric single-stranded poly(dG), but not poly(dA), could be observed in magnetic RNA-protein pull-down experiments. Experiments with TG2 inhibitors NC9 and GTPγS, which stabilise its open and closed conformation, respectively, revealed that the open conformation of the enzyme favoured RNA-binding. Biolayer interferometry revealed a high binding affinity between TG2 and RNA with a K value of 88 nm. Based on modelling and site-directed mutagenesis studies, we propose that superficial residues on the catalytic core domain (173-177 amino acids), present in a hidden position in the closed TG2 conformation, are involved in RNA binding. The present study demonstrates the previously uncharacterised RNA-binding ability of TG2, opening new avenues for understanding its multifunctionality.
转谷氨酰胺酶2(TG2)是一种具有独特多功能性的蛋白质,具有多种催化活性,如转谷氨酰胺酶、蛋白质二硫键异构酶、GTP酶和蛋白激酶,并参与多种生物学过程。根据RBP2GO数据库中的信息,TG2可作为一种RNA结合蛋白(RBP)。RBP参与转录后基因表达调控,从而影响RNA的功能,而RNA分子也可调节RBP的生物学活性。本研究旨在证实TG2在生理表达TG2的人脐静脉内皮细胞(HUVEC)中的这一新特性。首先,使用正交有机相分离从永生化HUVEC中分离紫外线交联的RNA-蛋白质复合物。与RBP2GO数据库相比,质谱鉴定出392种潜在的RBP,包括TG2和20种先前未描述的、与内皮相关的RBP。重组人TG2也被来自HUVEC的磁珠固定化总RNA拉下。在磁珠RNA-蛋白质拉下实验中,可以观察到TG2与具有二级结构的43聚体RNA分子以及同寡聚体单链聚(dG)而非聚(dA)之间形成复合物。分别稳定其开放和关闭构象的TG2抑制剂NC9和GTPγS的实验表明,该酶的开放构象有利于RNA结合。生物层干涉术显示TG2与RNA之间具有高结合亲和力,K值为88nm。基于建模和定点诱变研究,我们提出催化核心结构域(173-177个氨基酸)上的表面残基,在封闭的TG2构象中处于隐藏位置,参与RNA结合。本研究证明了TG2以前未被表征的RNA结合能力,为理解其多功能性开辟了新途径。